United States:
ML Strategies Health Care Preview – June 11th
To print this article, all you need is to be registered or login on Mondaq.com.
This week the Senate Finance Committee will mark up its opioid
package. Additionally, the HELP Committee will hear from Secretary
Azar on the Administration's effort to lower
prescription drug prices. For our complete review and
what else to watch for this week, click here.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
